Gregorio Marañón hospital performs Europe's first partial heart transplant on a baby

The Gregorio Marañón University Hospital has successfully performed Europe's first partial heart transplant on a seven-month-old baby. Mariami is recovering well after leaving Intensive Care just two days post-surgery. This breakthrough, endorsed by transplant authorities, combines pioneering techniques and could transform treatments for children with heart defects.

The public Gregorio Marañón University Hospital in Madrid has achieved a medical milestone by performing Europe's first partial heart transplant on a baby under one year old. The patient, seven-month-old Mariami, left the Intensive Care Unit after just two days and is now recovering well on the hospitalization ward.

Madrid's Health Counselor, Fátima Matute, visited the facility on Tuesday to celebrate the accomplishment. "This is a giant step that will revolutionize the world of transplants," Matute stated, praising the dedication, enthusiasm, and perseverance of the Cardiology service professionals, a national benchmark.

The technique, approved by the Regional Office and National Transplant Organization, involves implanting only a part of the heart in children requiring valve replacement surgery without complete muscle failure. Unlike current valve implants made from non-growing materials, this option allows the implant to develop with the patient, preventing multiple surgeries over their lifetime.

This procedure integrates two pioneering techniques from the same hospital: transplants with incompatible blood groups (2018) and controlled asystole donation (2021), marking a triple breakthrough. It will benefit children with congenital valve malformations, affecting around 4,000 births annually in Spain.

It also enhances the use of limited infant heart donations. While prioritizing full transplants, it enables scenarios such as extracting valves from hearts unsuitable for total transplant or reusing the recipient's valves in other patients. Matute commended the altruism of Madrid residents in donations, while President Isabel Díaz Ayuso congratulated the team on social media X, expressing pride in Madrid's public health system.

関連記事

Photorealistic illustration of a female hantavirus patient in critical care in a Paris ICU connected to an artificial lung, with medical staff.
AIによって生成された画像

French patient in critical condition with hantavirus in Paris

AIによるレポート AIによって生成された画像

A French passenger from the MV Hondius cruise ship is in intensive care in Paris with the most severe cardiopulmonary form of Andes hantavirus. She is receiving artificial oxygenation via an artificial lung. Emmanuel Macron stated that the situation is under control.

Hilario, a 3-year-old boy who has been on dialysis since birth, will receive a kidney transplant from his mother in the coming days. The surgery aims to improve his quality of life after several previous attempts failed. “His grit, joy, and will to live do not allow us to lower our arms,” said his mother Marina.

AIによるレポート

Clínica Medilaser hosted the First Symposium on Congenital Heart Diseases “Small Hearts, Big Challenges” at the Centro de Convenciones José Eustasio Rivera, as part of launching the National HUB for Congenital Heart Diseases. The event gathered specialists to enhance early diagnosis and local treatment for these conditions in southern Colombia, aiding children from Huila and Caquetá. Experts emphasized advances in technology and a patient- and family-centered approach.

Spanish health authorities confirmed on Monday the first positive hantavirus case in a Spanish national evacuated from the MV Hondius cruise ship. The asymptomatic patient, reported in good condition, awaits a confirmatory test while isolated at Madrid's Gómez Ulla hospital.

AIによるレポート

Argentine actor Diego Peretti, aged 63, underwent a scheduled procedure for a heart issue. A stent was placed at the Instituto Cardiovascular de Buenos Aires. TN Show confirmed the operation was successful.

このウェブサイトはCookieを使用します

サイトを改善するための分析にCookieを使用します。詳細については、プライバシーポリシーをお読みください。
拒否